search
Back to results

Helping Men Have Healthy Babies

Primary Purpose

HIV/AIDS, HIV Prevention

Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Safer Conception for Men with At Risk Partners
Sponsored by
Massachusetts General Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for HIV/AIDS

Eligibility Criteria

20 Years - 45 Years (Adult)MaleDoes not accept healthy volunteers

Inclusion Criteria:

  • Identifies as male
  • Not on ART, or initiated ART within the past 3 months
  • HIV-positive and status known for at least 1 (one) month,
  • in care/patient at iThembalabantu clinic
  • want to have a child in the next year,
  • with a stable sexual pregnancy partner for at least 6 months,
  • their pregnancy partner should be HIV-uninfected or HIV-status unknown,
  • their pregnancy partner should not be known to be currently pregnant,
  • have their own/ a mobile phone
  • be fluent in either English or isiZulu and,
  • able to participate in informed consent process
  • not sterilized or known to be infertile

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Safer Conception Intervention

    Arm Description

    Men will participate in 3 counseling sessions with a lay counselor. In the first session, the counselor will share information on the various safer conception strategies and help the participant think about developing a healthy plan. In the following 2 sessions, the counselor and the participant will work together to develop a healthy baby plan using motivational interviewing and problem solving. In the 2 booster sessions, the counselor and the participant will check in to evaluate the success of the plan and make changes as necessary.

    Outcomes

    Primary Outcome Measures

    HIV RNA Suppression
    Proportion of men achieving HIV-RNA suppression

    Secondary Outcome Measures

    Uptake of ART
    The proportion of men who initiate or continue ART
    Uptake of HIV-serostatus disclosure
    The proportion of men who report disclosure of HIV serostatus to pregnancy partner
    Use of timing condomless sex to peak fertility
    Through SMS surveys to assess weekly sexual behavior the study will evaluate the proportion of men who attempt to limit condomless sex to peak fertility

    Full Information

    First Posted
    December 7, 2018
    Last Updated
    April 15, 2020
    Sponsor
    Massachusetts General Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03818984
    Brief Title
    Helping Men Have Healthy Babies
    Official Title
    Safer Conception for HIV-infected Men Choosing to Conceive With At-risk Partners: Sinikithemba Kwabesilisa (Helping Men Have Healthy Babies)
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2020
    Overall Recruitment Status
    Completed
    Study Start Date
    November 6, 2015 (Actual)
    Primary Completion Date
    October 25, 2017 (Actual)
    Study Completion Date
    October 25, 2017 (Actual)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Massachusetts General Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    Yes

    5. Study Description

    Brief Summary
    Many men living with HIV (MLWH) want to have children. HIV-RNA suppression can minimize sexual HIV transmission risks while allowing for conception. The study will evaluate a safer conception intervention that leverages men's motivations to have healthy babies in order to promote serostatus disclosure and early ART initiation. The intervention is based on the investigators' Safer Conception Conceptual Framework, which considers individual, dyadic, and structural factors that affect periconception risk behavior.
    Detailed Description
    The study will evaluate and test a safer conception intervention that leverages men's motivations to have healthy babies in order to promote serostatus disclosure and early ART initiation. The intervention is based on a Safer Conception Conceptual Framework, which considers individual, dyadic, and structural factors that affect periconception risk behavior. The researchers will conduct an open pilot to refine the intervention. The study will enroll men who want to have children with uninfected or unknown status female partners. Men will participate in three study sessions offering motivational interviewing and problem solving to help men develop a plan to have a healthy baby. The counseling will explore safer conception options including safe disclosure, delaying conception attempts until on ART with viral suppression, STI testing and treatment, timing condomless sex to peak fertility. The primary outcome is HIV RNA suppression at 12 weeks. Secondary outcomes include acceptability, feasibility, early ART uptake, adherence, serostatus disclosure, couples HIV counseling and testing uptake, and limiting unprotected sex to peak fertility.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    HIV/AIDS, HIV Prevention

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Model Description
    Men will be offered 3 safer conception counseling sessions plus 2 booster sessions
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    28 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    Safer Conception Intervention
    Arm Type
    Experimental
    Arm Description
    Men will participate in 3 counseling sessions with a lay counselor. In the first session, the counselor will share information on the various safer conception strategies and help the participant think about developing a healthy plan. In the following 2 sessions, the counselor and the participant will work together to develop a healthy baby plan using motivational interviewing and problem solving. In the 2 booster sessions, the counselor and the participant will check in to evaluate the success of the plan and make changes as necessary.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Safer Conception for Men with At Risk Partners
    Intervention Description
    CBT based safer conception counseling with longitudinal follow-up and booster sessions. The primary outcome will be HIV RNA suppression at 6 months. Secondary outcomes include early ART uptake, adherence, serostatus disclosure, couples HIV counseling and testing uptake, and limiting unprotected sex to peak fertility.
    Primary Outcome Measure Information:
    Title
    HIV RNA Suppression
    Description
    Proportion of men achieving HIV-RNA suppression
    Time Frame
    12 weeks
    Secondary Outcome Measure Information:
    Title
    Uptake of ART
    Description
    The proportion of men who initiate or continue ART
    Time Frame
    12 weeks
    Title
    Uptake of HIV-serostatus disclosure
    Description
    The proportion of men who report disclosure of HIV serostatus to pregnancy partner
    Time Frame
    12 weeks
    Title
    Use of timing condomless sex to peak fertility
    Description
    Through SMS surveys to assess weekly sexual behavior the study will evaluate the proportion of men who attempt to limit condomless sex to peak fertility
    Time Frame
    12 weeks

    10. Eligibility

    Sex
    Male
    Minimum Age & Unit of Time
    20 Years
    Maximum Age & Unit of Time
    45 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Identifies as male Not on ART, or initiated ART within the past 3 months HIV-positive and status known for at least 1 (one) month, in care/patient at iThembalabantu clinic want to have a child in the next year, with a stable sexual pregnancy partner for at least 6 months, their pregnancy partner should be HIV-uninfected or HIV-status unknown, their pregnancy partner should not be known to be currently pregnant, have their own/ a mobile phone be fluent in either English or isiZulu and, able to participate in informed consent process not sterilized or known to be infertile

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    35507406
    Citation
    Matthews LT, Psaros C, Mathenjwa M, Mosery N, Greener LR, Khidir H, Hovey JR, Pratt MC, Harrison A, Bennett K, Bangsberg DR, Smit JA, Safren SA. Demonstration and Acceptability of a Safer Conception Intervention for Men With HIV in South Africa: Pilot Cohort Study. JMIR Form Res. 2022 May 4;6(5):e34262. doi: 10.2196/34262.
    Results Reference
    derived

    Learn more about this trial

    Helping Men Have Healthy Babies

    We'll reach out to this number within 24 hrs